FibroGen, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
ARMISTICE CAPITAL, LLC | 02/14/2025 | 6.80 M | $3.60 M | 0.00% | 6.77% |
VANGUARD GROUP INC | 02/11/2025 | 5.88 M | $3.11 M | -0.09% | 5.85% |
PRIMECAP MANAGEMENT CO/CA/ | 02/10/2025 | 4.62 M | $2.44 M | -53.43% | 4.59% |
ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 3.91 M | $2.07 M | 0.00% | 3.89% |
BLACKROCK, INC. | 02/07/2025 | 2.38 M | $1.26 M | -0.60% | 2.36% |
683 CAPITAL MANAGEMENT, LLC | 02/14/2025 | 2.14 M | $1.13 M | 0.00% | 2.13% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 1.36 M | $719,438 | 80.41% | 1.35% |
MARSHALL WACE, LLP | 02/13/2025 | 1.27 M | $670,721 | -12.41% | 1.26% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.06 M | $560,549 | -2.32% | 1.05% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 878,400 | $465,113 | 18.26% | 0.87% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 830,605 | $439,805 | -13.92% | 0.83% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 604,421 | $320,041 | 19.56% | 0.60% |
MACKENZIE FINANCIAL CORP | 02/20/2025 | 546,959 | $289,615 | 416.60% | 0.54% |
FMR LLC | 02/13/2025 | 414,580 | $219,520 | 8.17% | 0.41% |
SQUAREPOINT OPS LLC | 02/14/2025 | 386,752 | $204,785 | 100.00% | 0.38% |
ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 351,851 | $186,305 | -54.17% | 0.35% |
STATE STREET CORP | 02/14/2025 | 343,053 | $181,647 | 0.26% | 0.34% |
FRANKLIN STREET ADVISORS INC /NC | 01/10/2025 | 200,000 | $106,000 | 100.00% | 0.20% |
UBS GROUP AG | 02/14/2025 | 196,635 | $104,020 | 697.29% | 0.20% |
VANTAGE CONSULTING GROUP INC | 02/12/2025 | 195,707 | $103,627 | 0.00% | 0.19% |
NORTHERN TRUST CORP | 02/14/2025 | 177,743 | $94,115 | 0.45% | 0.18% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 162,400 | $86,072 | -29.39% | 0.16% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 134,211 | $71,065 | 142.42% | 0.13% |
CITADEL ADVISORS LLC | 02/14/2025 | 129,200 | $68,411 | 6.25% | 0.13% |
GROUP ONE TRADING, L.P. | 02/14/2025 | 127,499 | $67,511 | 100.00% | 0.13% |
SEI INVESTMENTS CO | 02/11/2025 | 126,754 | $67,116 | -43.58% | 0.13% |
PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 116,000 | $61,000 | -25.88% | 0.12% |
HIGHTOWER ADVISORS, LLC | 02/07/2025 | 102,988 | $54,532 | 0.00% | 0.10% |
CI PRIVATE WEALTH, LLC | 02/10/2025 | 102,103 | $54,064 | 0.00% | 0.10% |
XTX TOPCO LTD | 02/13/2025 | 96,025 | $50,845 | 423.81% | 0.10% |
ACCEL WEALTH MANAGEMENT | 01/21/2025 | 95,600 | $50,620 | 0.00% | 0.10% |
ENGINEERS GATE MANAGER LP | 02/14/2025 | 85,233 | $45,131 | 0.00% | 0.08% |
VELAN CAPITAL INVESTMENT MANAGEMENT LP | 02/14/2025 | 80,000 | $42,360 | 100.00% | 0.08% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 65,800 | $34,874 | -40.99% | 0.07% |
NORTHEAST FINANCIAL CONSULTANTS INC | 02/14/2025 | 54,699 | $28,964 | 0.00% | 0.05% |
HSBC HOLDINGS PLC | 02/14/2025 | 52,211 | $26,758 | 0.00% | 0.05% |
TWO SIGMA SECURITIES, LLC | 02/14/2025 | 51,126 | $27,071 | 100.00% | 0.05% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 45,308 | $23,990 | -12.14% | 0.05% |
CITADEL ADVISORS LLC | 02/14/2025 | 39,600 | $20,968 | 14.78% | 0.04% |
SIMPLEX TRADING, LLC | 02/11/2025 | 38,500 | $20,000 | 100.00% | 0.04% |
CITIGROUP INC | 02/12/2025 | 38,270 | $20,264 | 36,698.08% | 0.04% |
MORGAN STANLEY | 02/14/2025 | 37,958 | $20,099 | -9.01% | 0.04% |
VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 02/10/2025 | 37,228 | $19,712 | 184.88% | 0.04% |
QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 34,976 | $18,520 | -45.82% | 0.03% |
POINT72 ASIA (SINGAPORE) PTE. LTD. | 02/14/2025 | 34,521 | $18,279 | -10.27% | 0.03% |
STIFEL FINANCIAL CORP | 02/13/2025 | 27,031 | $14,316 | -42.53% | 0.03% |
WOLVERINE TRADING, LLC | 02/14/2025 | 24,200 | $12,862 | 100.00% | 0.02% |
HRT FINANCIAL LP | 02/14/2025 | 24,084 | $12,000 | 100.00% | 0.02% |
SAVVY ADVISORS, INC. | 02/13/2025 | 20,587 | $10,901 | 100.00% | 0.02% |
JANE STREET GROUP, LLC | 02/14/2025 | 19,646 | $10,403 | -66.37% | 0.02% |
FibroGen, Inc. institutional Ownership - FAQ's
During the previous two years, 130 institutional investors and hedge funds held shares of FibroGen, Inc.. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 6.8 M
VANGUARD GROUP INC: 5.88 M
PRIMECAP MANAGEMENT CO/CA/: 4.62 M
ACADIAN ASSET MANAGEMENT LLC: 3.91 M
BlackRock, Inc.: 2.38 M
683 Capital Management, LLC: 2.14 M
36.06% of FibroGen, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 47.88 M shares in the last 24 months. This purchase volume represents approximately $13.41 M in transactions.